Europe Neuromodulation Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Technology ; Application

Europe Neuromodulation Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Technology ; Application

  • November 2020 •
  • 117 pages •
  • Report ID: 5999694 •
  • Format: PDF
The Europe neuromodulation market is projected to reach US$ 4,741.75 million by 2027 from US$ 2,296.33 million in 2019; it is estimated to grow at a CAGR of 9.8% from 2020 to 2027. The market growth is attributed to increasing incidence of neurological disorders and developments in neuromodulation technology.
Depression is the most common neurological disorder among all age groups.In the developing regions, most people suffer from depression owing to various socioeconomic factors, including financial stress and poverty.

Other neurological disorders such as dystonia, Parkinson’s disease, and obsessive-compulsive disorder are usually observed in elderly population. As per the European Academy of Neurology data, in 2019, ~307.85 million people in European Union were suffering from neurological diseases. The growing prevalence of neurological disorders is consequently propelling the demand for neuromodulators as these help in relieving neurological symptoms
In 2019, the external (non-invasive) neuromodulation based on technology segment accounted for the largest share of the neuromodulation market in Europe.
A few of the primary and secondary sources referred to while preparing the report on the Europe neuromodulation market are and European Academy of Neurology.
Loading...

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.